Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Cannabis company Aurora Cannabis Inc (NYSE:ACB) (TSE: ACB) reported fiscal fourth-quarter results last week that looked "bad" on the surface, but look even worse when digging beyond the headline numbers, according to Stifel.
The Analyst
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
W. Andrew Carter downgraded Aurora's Toronto-listed stock rating from Hold to Sell with a price target lowered from CA$7 ($5.29) to CA$5 ($3.78).
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
The Thesis
Aurora's shortfall in the quarter is evident due to a reported $20.1 million of bulk wholesale trim sales that are unlikely to repeat at the same level, Carter said in a Sunday downgrade note. (See his track record here.)
The headline net cannabis revenue of CA$94.7 million suggests a net cannabis revenue base closer to CA$75 million versus Stifel's estimate of CA$92.5 million.
The "lower quality" performance marks a reversal from the company's update in August, when it alluded to a strong in-market performance and a leadership position in Canada, the analyst said.
Instead, the company recorded CA$44.9 million in adult use sales in Canada, which implies that it lags Canopy Growth Corp (NYSE:CGC), which reported CA$49 million in adult use sales, including a CA$6.5-million charge for potential returns, he said.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Aurora's report suggests it is far removed from achieving profitability, and any sequential improvement in the reported quarter was "underwhelming" when considering unique events, like a CA$14.9-million benefit from accounting changes, Carter said.
Looking forward, the analyst said he expects a "more muted" adult use market in the first half of 2020 and sees a likelihood of Aurora's sales hitting a plateau in the near-term.
Sales are likely to accelerate in the back half of the year from "Cannabis 2.0," but the Stifel is moving its full-year revenue target lower from CA$600 million to CA$485 million.
The EBITDA loss for fiscal 2020 was also revised from CA$32 million to a loss of CA$89 million.
The company is likely need to oversee a "significant" capital market raise before the end of the first quarter of 2020 and will ultimately find itself in a difficult position to aggressively invest in the U.S. market, according to Stifel.
Price Action
Aurora's U.S.-listed shares were down 6.89% at $5.54 at the time of publication Monday.
Related Links:
Aurora Investors Aren't Feeling The Buzz After Q4 Print: 2 Analyst Takes
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.